SelectScience
Join Free
NewsLife Sciences

Biomarkers of Prostate Cancer Progression Identified with Biochemical Profiling Technology

Metabolon
17 Feb 2009
Samantha Rosoman
Campaign Coordinator

Product news

Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced that the company’s global biochemical profiling technology has been used to identify biomarkers indicative of prostate cancer progression. The results of the study, conducted with researchers at the University of Michigan, will be published in the February 12 issue of Nature in a paper titled “Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression”.

The study described in the Nature paper was undertaken to better understand and profile the metabolic changes associated with prostate cancer progression. Using Metabolon’s biochemical profiling to generate global, non-targeted metabolic analysis of tissue, urine and plasma samples, the researchers were able to identify a series of metabolites (including sarcosine) that are key potential predictors of cancer aggressiveness.

Applying the biomarkers identified in this study, under exclusive license from the University of Michigan, Metabolon plans to make available a research tool for investigators to better understand tumor aggressivity in prostate cancer and other cancers.

“Gaining mechanistic understanding of a disease is the key to discovering new diagnostics,” said John Ryals, chief executive with Metabolon. “The exciting results of this study are an example of just how valuable metabolomic profiling is in the identification of biomarkers.”

The lead author of the paper, Dr. Arul M. Chinnaiyan, M.D., Ph.D., director, Michigan Center for Translational Pathology and S.P. Hicks endowed professor of pathology, led the research studies that resulted in the discovery of the prostate cancer progression biomarkers described in the Nature publication. Dr. Chinnaiyan’s team focuses on the development of new molecular tests and therapies for human disease with a primary focus on cancer.

The complete publication detailing the results of this study can be accessed online by clicking on the article webpage link at the right of the page, as well as in the February 12, 2009 print edition of Nature.

Links

MetabolonCompany website

Tags

Genome AnalysisGenomics, the study of genomes, includes functional genomics, evolutionary genomics and comparative genomics. There are many genomic technologies such as DNA sequencing of whole genomes, computational biology and bioinformatics. DNA and nucleic acids must be isolated and concentrated from cells for analysis with kits, automated analyzers and software. Other useful technologies for studying genomics include PCR, microarrays and electrophoresis.Cell Lines Stem Cells and Primary CellsPrimary cell cultures, established cell lines and stem cells are vital for <i>in vitro</i> and <i>ex vivo</i> experimentation. High-quality cells, optimized for your applications, alongside optimized cell substrates, growth medium and supplements, are critical for experimental success. Explore a range of cells suitable for your applications, including isogenic cell lines, competent cells, induced pluripotent stem cell (iPSC)-derived cell lines, fungal/bacterial/mammalian cell lines, stem cells and cancer cell lines. Find the best cells for your research in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.

Related articles

Biomarkers of Prostate Cancer Progression Identified with Biochemical Profiling Technology